BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30036949)

  • 41. Computational studies of G protein-coupled receptor complexes: Structure and dynamics.
    Sensoy O; Almeida JG; Shabbir J; Moreira IS; Morra G
    Methods Cell Biol; 2017; 142():205-245. PubMed ID: 28964337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QSAR modeling of GPCR ligands: methodologies and examples of applications.
    Tropsha A; Wang SX
    Ernst Schering Found Symp Proc; 2006; (2):49-73. PubMed ID: 17703577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-based and fragment-based GPCR drug discovery.
    Andrews SP; Brown GA; Christopher JA
    ChemMedChem; 2014 Feb; 9(2):256-75. PubMed ID: 24353016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of multiscale simulations on GPCRs.
    Durdagi S; Dogan B; Erol I; Kayık G; Aksoydan B
    Curr Opin Struct Biol; 2019 Apr; 55():93-103. PubMed ID: 31082696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
    Lee Y; Lazim R; Macalino SJY; Choi S
    Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of structure of G-protein coupled receptors and of bound ligands, with applications for drug design.
    Li Y; Goddard WA
    Pac Symp Biocomput; 2008; ():344-53. PubMed ID: 18229698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Dynamic Process of Drug-GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics.
    Schneider S; Provasi D; Filizola M
    Methods Mol Biol; 2015; 1335():277-94. PubMed ID: 26260607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.
    Heifetz A; Southey M; Morao I; Townsend-Nicholson A; Bodkin MJ
    Methods Mol Biol; 2018; 1705():375-394. PubMed ID: 29188574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation.
    Peeters MC; van Westen GJ; Li Q; IJzerman AP
    Trends Pharmacol Sci; 2011 Jan; 32(1):35-42. PubMed ID: 21075459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding Kinetics and Pathways of Ligands to GPCRs.
    Strasser A; Wittmann HJ; Seifert R
    Trends Pharmacol Sci; 2017 Aug; 38(8):717-732. PubMed ID: 28645833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery?
    Filizola M
    Life Sci; 2010 Apr; 86(15-16):590-7. PubMed ID: 19465029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges and Opportunities in Drug Discovery of Biased Ligands.
    Rodríguez-Espigares I; Kaczor AA; Stepniewski TM; Selent J
    Methods Mol Biol; 2018; 1705():321-334. PubMed ID: 29188569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.
    Kortagere S; Welsh WJ
    J Comput Aided Mol Des; 2006 Dec; 20(12):789-802. PubMed ID: 17054015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling G protein-coupled receptors and their interactions with ligands.
    Costanzi S
    Curr Opin Struct Biol; 2013 Apr; 23(2):185-90. PubMed ID: 23415855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations.
    Cuzzolin A; Sturlese M; Deganutti G; Salmaso V; Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2016 Apr; 56(4):687-705. PubMed ID: 27019343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The family of G protein-coupled receptors: an example of membrane proteins.
    Tikhonova IG; Fourmy D
    Methods Mol Biol; 2010; 654():441-54. PubMed ID: 20665280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Membrane potentials regulating GPCRs: insights from experiments and molecular dynamics simulations.
    Vickery ON; Machtens JP; Zachariae U
    Curr Opin Pharmacol; 2016 Oct; 30():44-50. PubMed ID: 27474871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.